Polycationic nanoparticles synthesized using ARGET ATRP for drug delivery

Representation of the polycationic nanoparticle and of the biomaterial property comparisons for ARGET ATRP and UV-initiated formulations (with 30mol of hydrophobic tBMA monomer per 100mol cationic DEAEMA monomer in the feed). [Display omitted] This work provides a systemic comparison for ARGET ATRP...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmaceutics and biopharmaceutics Vol. 84; no. 3; pp. 472 - 478
Main Authors Forbes, D.C., Creixell, M., Frizzell, H., Peppas, N.A.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Representation of the polycationic nanoparticle and of the biomaterial property comparisons for ARGET ATRP and UV-initiated formulations (with 30mol of hydrophobic tBMA monomer per 100mol cationic DEAEMA monomer in the feed). [Display omitted] This work provides a systemic comparison for ARGET ATRP and UV-initiated polycationic nanoparticles for drug delivery and a guide to deciding which type of polycationic nanoparticles have the best properties for specific applications. Polycationic nanoparticles were synthesized using a previously developed UV-initiated photoemulsion polymerization or a newly developed ARGET ATRP synthesis technique. The effect of the ratio of hydrophobic monomer in the feed was evaluated. Increasing the feed ratio of hydrophobic monomer was necessary to maintain biocompatibility and pH-responsive membrane disruptive characteristics when switching from the UV-initiated polymerization to ARGET ATRP. The resulting polycationic nanoparticles have utility as drug delivery carriers for hydrophobic drugs and/or nucleic acids.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0939-6411
1873-3441
DOI:10.1016/j.ejpb.2013.01.007